Correlation Between Pharvaris and Pmv Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Pharvaris and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharvaris BV and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Pharvaris and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Pmv Pharmaceuticals.

Diversification Opportunities for Pharvaris and Pmv Pharmaceuticals

0.42

Correlation Coefficient

Pharvaris  Pmv Pharmaceuticals

Very weak diversification

The 3 months correlation between Pharvaris and Pmv is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Pharvaris i.e., Pharvaris and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pharvaris and Pmv Pharmaceuticals

Given the investment horizon of 90 days Pharvaris BV is expected to generate 0.92 times more return on investment than Pmv Pharmaceuticals. However, Pharvaris BV is 1.08 times less risky than Pmv Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  850.00  in Pharvaris BV on February 8, 2025 and sell it today you would earn a total of  854.00  from holding Pharvaris BV or generate 100.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Pharvaris BV  vs.  Pmv Pharmaceuticals

Pharvaris BV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Pharvaris is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pmv Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pmv Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in June 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Pharvaris and Pmv Pharmaceuticals

The main advantage of trading using opposite Pharvaris and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.

The idea behind Pharvaris BV and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.